US Patent 8129343 Acylated GLP-1 compounds
Patent 8129343 was granted and assigned to Novo Nordisk on March, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+71 characters)
Article
Patent abstract
Protracted GLP-1 compounds and therapeutic uses thereof.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Jesper Lau0
Paw Bloch0
Thomas Kruse Hansen0
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08129343 Acylated GLP-1 compounds US Patent 8129343 Acylated GLP-1 compounds
Infobox
Patent Number
081293430
Patent Number
81293430
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081293430
Date of Patent
March 6, 2012
0Patent Application Number
119088340
Date Filed
March 20, 2006
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08129343 Acylated GLP-1 compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08129343
Date of patent
March 6, 2012
Patent application number
11908834
Date Filed
March 20, 2006
Patent primary examiner
Find more entities like US Patent 8129343 Acylated GLP-1 compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
